RxDoctor Payments Data

Makenzie Abbott, PA

Physician Assistant · Versailles, MONPI 1003436585

Payments from drug & device makers

$667in general payments, 2019–2025

Across 41 payments — averaging $16.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$203
  • Amgen$93
  • AstraZeneca$81
  • Boehringer Ingelheim$55
  • Pfizer$42
  • Mylan Specialty L.p.$37
  • plus $156 from 8 others

What the payments were for

  • Food & beverage$667100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$667 in reported general payments places this provider in the 65th percentile of 1,380 physician assistant providers in Missouri.

See all physician assistant providers in Missouri

Medicare billing

Part B allowed, 2024
$32,109
Medicare patients
212
Services billed
563

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin71$62,370
MounjaroTirzepatide47$48,915
TrulicityDulaglutide44$48,032
EliquisApixaban57$44,311
OzempicSemaglutide41$38,341
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$31,222
XareltoRivaroxaban26$25,462
Breztri AerosphereBudesonide/Glycopyr/Formoterol30$18,749
Combivent RespimatIpratropium/Albuterol Sulfate26$17,328
JanuviaSitagliptin Phosphate18$17,203
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$12,509
LinzessLinaclotide14$10,977
Fiasp FlextouchInsulin Aspart (Niacinamide)13$9,034
MyrbetriqMirabegron14$8,961
Invokamet XrCanagliflozin/Metformin Hcl12$7,438

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$28$96,94791 claims
Boehringer IngelheimJardiance, Combivent Respimat, Synjardy Xr, Stiolto Respimat$55$94,177123 claims
GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta$15$44,83172 claims
PfizerEliquis$42$44,31157 claims
Novo NordiskOzempic$30$38,34141 claims
AstraZenecaBreztri Aerosphere, Symbicort$81$24,85742 claims
AbbVieLinzess$203$10,97714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,380 physician assistant providers in Missouri.

Other physician assistant in Versailles

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →